Immunotherapy With Baricitinib and Sirolimus, Alone and in Combination, for the Control of HIV-1 Replication After Antiretroviral Treatment Interruption
Clinical trial NCT07081763 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07081763
- Sponsor
- ANRS, Emerging Infectious Diseases
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-05-01
- Primary completion
- 2029-05-01
- Enrollment
- 191
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.